ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effects.

Anthea Wirges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.